Home Compare BF-B vs BMY
Stock Comparison · Single-driver result

Brown-Forman vs Bristol-Myers Squibb Company: Which Stock Looks Stronger in 2026?

Bristol-Myers Squibb Company holds the cleaner structural position, with stability as the main driver and growth adding further support. On the market side, Bristol-Myers Squibb Company is in better shape — its trend is intact while Brown-Forman's trend has broken down. That puts structure and market broadly in agreement — Bristol-Myers Squibb Company's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the S&P 500 universe, making them directly comparable.

Updated 2026-05-17

The comparison is mainly decided in stability, with the rest of the profile carrying less weight. Bristol-Myers Squibb Company leads by 10 points on the overall comparison score.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #26
within Brown-Forman Corporation's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in capital structure and revenue growth trajectory.

Similarity drivers
capital structurerevenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BF-B
Brown-Forman Corporation
46
Peer-Score
Signal qualitylow
Peer basis: S&P 500
vs
BMY
Bristol-Myers Squibb Company
56
Peer-Score
Signal qualitylow
Peer basis: S&P 500

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: BF-B vs BMY Profitability 49 40 Stability 15 59 Valuation 83 86 Growth 19 30 BF-B BMY
Gap Ranking
#1 Stability +44
#2 Growth +11
#3 Profitability +9
#4 Valuation +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BF-B and BMY Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BF-BBMY Relative valuation Structural strength

The setup stays mixed because structure and the price setup do not align cleanly in one direction.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Entry today — historical context

Where BF-B and BMY each sit in their own 5-year price and valuation history.

BASED ON 5-YEAR HISTORY BF-B Lower · below norm 0th 50th 100th 64 pct gap BMY Neutral · near norm 0th 50th 100th 5th 69th
Today BF-B sits in the lower portion of its own 5-year history (5th percentile), while BMY sits higher in its own history (69th). Within each stock's own 5-year context, BF-B is at a historically more favourable entry position than BMY. This reflects entry timing, not which company is structurally stronger — peer-relative analysis is a separate question addressed above.

Describes historical entry positioning only. Descriptive — not investment advice.

Relative Position vs Comparable Companies
Stability
Bristol-Myers Squibb Company sits in the stronger part of the group on stability, while Brown-Forman Corporation is closer to mid-pack.
Growth
Neither side looks especially strong on growth, though Bristol-Myers Squibb Company still ranks somewhat higher.
Stability — Dominant Gap
BF-B
15
BMY
59
Gap+44in favour of BMY

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Capital efficiency also runs the other way, with a 4.4-point ROIC edge acting as a real counterforce.

What this means for the comparison

Stability is the clearest driver, and growth also supports Bristol-Myers Squibb Company's broader structural position.

Explore full peer positioning in AssetNext

Break down the BF-B vs BMY comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how BF-B and BMY each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.